<DOC>
	<DOCNO>NCT00806364</DOCNO>
	<brief_summary>This protocol design provide blood , buccal mucosa bone marrow aspirate sample approximately 250 , healthy volunteer donor use vitro study mast cell , mastocytosis , allergic disease . Non-atopic donor recruit donate blood , bone marrow , and/or buccal mucosa sample use conventional technique . The investigational nature study blood , bone marrow buccal mucosa sample use , well risk benefit donation process explain donor , sign informed consent document obtain . Donors compensate accord establish schedule base duration discomfort donation . Samples provide protocol use solely vitro research . Blood , bone marrow , buccal mucosa sample assign unique product number study investigator list protocol serve custodian code link product donor identity . The nature vitro study blood collect study use subject protocol describe general term . The sample use several Institutional Review Board ( IRB ) -approved Laboratory Allergic Diseases ( LAD ) protocols . This protocol design assure adequate complete inform consent , counsel , protection study subject accord IRB , Office Human Subjects Research ( OHSR ) , Office Human Research Protections ( OHRP ) applicable Federal regulatory standard .</brief_summary>
	<brief_title>Normal Blood , Bone Marrow Buccal Mucosa Protocol</brief_title>
	<detailed_description>This protocol design provide blood , skin , buccal mucosa bone marrow aspirate sample approximately 250 healthy volunteer donor use vitro study cell immune system , mastocytosis , allergic disease . Participants donate sample use conventional technique . The investigational nature study sample use , well risk benefit donation process , explain donor , sign informed consent document obtain . Donors compensate accord establish schedule base duration discomfort donation . Samples provide protocol use solely vitro research . Samples assign unique product number , study investigator list protocol serve custodian code link product donor identity . The nature vitro study blood collect study use subject protocol describe general term . The sample use several Institutional Review Board ( IRB ) -approved Laboratory Allergic Diseases ( LAD ) protocols . This protocol design assure adequate complete inform consent , counsel , protection study subject accord IRB , Office Human Subjects Research ( OHSR ) , Office Human Research Protections ( OHRP ) applicable Federal regulatory standard .</detailed_description>
	<criteria>INCLUSION CRITERIA : Ability sign inform consent . Healthy male female 1865 year age . Willing sample store future research . EXCLUSION CRITERIA : History immune deficiency , HIV infection cancer . History chronic hepatitis B and/or C infection . History chronic anemia . A known clotting disorder take medication interfere blood clotting , : aspirin , heparin , Coumadin* Current pregnancy . Have take investigational drug last 6 month may affect normal process blood cell . Any condition view principal investigator ( PI ) would make subject unsuitable enrollment study . * Coumadin and/or heparin treatment stop subject participate protocol . If Coumadin heparin recently discontinue , subject enrol , bone marrow procedure perform PT PTT within normal range . For agent interfere blood clot without prolong PT , 7day washout period require bone marrow sample . ( Procedure ) EXCLUSION CRITERIA Hemoglobin less NIH Clinical Center CRIS normal range . Platelets le 100,000/mm ( 3 ) . PT PTT great NIH Clinical Center CRIS normal range Positive bHCG . EKG change suggestive cardiovascular disease . Unable unwilling bone marrow biopsy perform without use conscious sedation , use local anesthetic procedure Any lab value may put subject risk procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 7, 2016</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Allergy</keyword>
	<keyword>Bone Marrow</keyword>
	<keyword>Buccal Mucosa</keyword>
	<keyword>HV</keyword>
	<keyword>Healthy Volunteer</keyword>
</DOC>